The document is a regulatory filing submitting the transcript of a conference call with analysts and investors discussing financial results for the quarter and half year ended 30th September, 2026.
The event is specifically described as a "Conference call with Analysts / Investors on Financial Results" for Q2 FY27.
The transcript was filed on 29th October, 2026, following up on a previous letter dated 09th October, 2026.
The filing is made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The transcript has been placed on the company's website at: https://torrentpharma.com/pdf/investors/Q2-FY26-27_Earnings-Call-Transcript.pdf
The document represents compliance disclosure indicating that the earnings call discussion has been properly documented and made available to regulators and investors.
Additional Notes Section
The document is a formal compliance letter addressed to both BSE Limited and National Stock Exchange of India Ltd.
No financial data or specific management commentary is included in this announcement document - it solely notifies about the availability of the transcript.
The document carries a digital signature from CHINTAN M. TRIVEDI, Company Secretary, confirming its authenticity.
